Vioxx fiasco forces Merck to pay double on 10 year global

18 Feb 2005

Merck's troubles hit home this week when it was forced to pay almost double the margin it would previously have paid for a $1bn 10 year global.

In its first deal since its painkiller Vioxx was removed from the market, Merck offered 78bp for the ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.